元智大學生物技術與工程研究所 | 蕭聖謀
公告
113學年度第2學期畢業生領取學位證書方式時間及相關事項 歡迎參加2025第十五屆國際綠色永續生物科技研討會 賀！ 本所同學參加「2024國際生物催化暨農業生物技術臺灣年會」榮獲佳績！ 元智大學研發薄膜式核酸感測器 亞洲競賽奪冠 元智大學榮獲美國喬治亞理工首屆「亞洲創新創意競賽」第一名 105學年度起入學之碩士班（含碩士在職專班）與博士班學生，請於入學第一學期末前完成學術研究倫理教育線上課程 恭賀!本所同學參加2024第十五屆桃園四校生命科技領域學術研討會 榮獲佳績! SDG創新創業競賽-薄膜核酸感測商業計畫得獎 賀! 本所 魏毓宏教授 榮登2023年及2022年 全球前2%頂尖科學家榜單
元智大學生物技術與工程研究所
元智大學生物技術與工程研究所

學系成員

蕭聖謀 教授暨亞東醫院婦產部主任

學歷

    台大醫學士, 台大臨床醫學研究所碩士 

經歷

現任：亞東醫院婦產部主任

台大醫院婦產部總醫師

婦癌及婦女泌尿研修醫師

台大醫院婦產部兼任主治醫師

台灣婦癌醫學會婦癌專科醫師

台灣婦女泌尿暨骨盆醫學會專科醫師

台灣婦產科內視鏡暨微創醫學會專科醫師

亞太婦科內視鏡暨微創醫學會專科醫師

台灣周產期醫學會專科醫師

臺灣臨床試驗婦癌研究聯盟亞東醫院主持人

Memorial Sloan-Kettering Cancer Center及Florida Hospital婦癌及達文西手術研究

新加坡大學和香港大學達文西婦癌研究

日本川崎醫院子宮鏡手術研究

台灣婦女泌尿暨骨盆醫學會2008,2009年,2013年,2014年(第一名)和 2016年優秀論文獎

國際尿失禁醫學會2014年優秀論文獎

達文西手術多篇國外英文期刊論文發表

台灣福爾摩莎婦女泌尿學會常務監事

國際婦癌醫學會(IGCS)會員

亞洲婦癌醫學會(ASGO)會員

研究專長

醫學--婦產科醫學

期刊論文

Since 2022-

  1. Ting WH, Chen HH, Wei MC, Sun HD, Hsiao SM*. Intraperitoneal Chemotherapy without Bevacizumab versus Intravenous Chemotherapy with Bevacizumab as the Frontline Adjuvant Therapy in Advanced Ovarian Cancer. Cancers (Basel). 2024 Oct 3;16(19):3382. doi: 10.3390/cancers16193382.
  2. Chung CH, Tsai CC, Wang HF, Chen HH, Ting WH, Hsiao SM*. Predictors of Infused Distending Fluid Volume in Hysteroscopic Myomectomy. Medicina (Kaunas). 2024 Aug 30;60(9):1424. doi: 10.3390/medicina60091424.
  3. Ting WH, Chen HH, Hsieh SW, Wei MC, Hsiao SM*. Comparison of clinical outcomes in women with surgically treated early primary cervical cancer: Lymphadenectomy versus sentinel lymph node biopsy. J Chin Med Assoc. 2024 Sep 17. doi: 10.1097/JCMA.0000000000001169.
  4. Hsiao SM*, Chang SR. Response to letter to the editor "Effect of tibolone versus hormone replacement therapy on lower urinary tract symptoms and sexual function". J Formos Med Assoc. 2024 Aug 29:S0929-6646(24)00397-8. doi: 10.1016/j.jfma.2024.08.029
  5. Wu PC#, Hsiao SM#, Lin HH*. The prevalence of overt, occult, and no-demonstrated stress urinary incontinence and their clinical and urodynamic findings in women with advanced-stage cystoceles. J Formos Med Assoc. 2024 Oct;123(10):1064-1069. doi: 10.1016/j.jfma.2024.06.011
  6. Wu PC#, Hsiao SM#, Lin HH*. Age-specific prevalence, clinical and urodynamic findings of detrusor underactivity and bladder outlet obstruction in female voiding dysfunction. Int J Gynaecol Obstet. 2024 Nov;167(2):797-803. doi: 10.1002/ijgo.15705.
  7. Hsiao SM*. Predictors of non-persistence in women with overactive bladder syndrome. Sci Rep. 2024 Mar 29;14(1):7499. doi: 10.1038/s41598-024-58036-4.
  8. Hsiao SM*, Chang SR. Effect of tibolone versus hormone replacement therapy on lower urinary tract symptoms and sexual function. J Formos Med Assoc. 2024 Jun;123(6):710-715. doi: 10.1016/j.jfma.2023.12.007
  9. Hsiao SM*, Liao SC. Effect of tibolone vs hormone replacement therapy on climacteric symptoms and psychological distress. J Chin Med Assoc. 2024 Feb 1;87(2):189-195. doi: 10.1097/JCMA.0000000000001012.
  10. Hsiao SM, Lin HH*. Feasibility and clinical implications of 3-day bladder diary derived classification of female storage lower urinary tract symptoms. Sci Rep. 2022 Nov 25;12(1):20339. doi: 10.1038/s41598-022-24539-1.
  11. Wu CY, Tseng LM, Chen HH, Hsieh CH, Hsiao SM*. Fatal rectovaginal fistula in post-radiotherapy locally advanced cervical cancer patients. Taiwan J Obstet Gynecol. 2022 Nov;61(6):1069-1072. doi: 10.1016/j.tjog.2022.01.007.
  12. Wu LC, Peng FS, Leung C, Lu HF, Lin HH, Hsiao SM*. Comparison of cesarean section rates between obstetricians preferring labor induction at early versus late gestational age. Taiwan J Obstet Gynecol. 2022 Sep;61(5):847-853. doi: 10.1016/j.tjog.2022.05.016.
  13. Hsiao SM, Tu FC, Su TC, Wu PC, Lin HH*. Impact of mirabegron versus solifenacin on autonomic function and arterial stiffness in female overactive bladder syndrome: a randomized controlled trial. Sci Rep. 2022 Aug 20;12(1):14219. doi: 10.1038/s41598-022-18391-6.
  14. Chen HH, Hou PY, Ting WH, Shueng PW, Hsiao SM*. Feasibility and Safety of Intraoperative Radiotherapy with Low Energy X-ray Photon Therapy for Recurrent Gynecological Cancer: A Case Series. Life (Basel). 2022 May 5;12(5):685. doi: 10.3390/life12050685.
  15. Huang PH, Tsai MC, Ting WH, Chen HH, Lin HH, Hsiao SM*. Predictors of surgical outcomes of laparoscopic myomectomy with barbed sutures: Comparison of V-Loc and Quill barbed sutures. Int J Gynaecol Obstet. 2022 Sep;158(3):757-759. doi: 10.1002/ijgo.14276
  16. Yang SP, Chen HH, Peng FH, Hsiao SM*. Obstetric measures to decrease the spread of SARS-CoV-2 infection during labor in a conventional labor room. Taiwan J Obstet Gynecol. 2022 May;61(3):568-569. doi: 10.1016/j.tjog.2022.03.034.
  17. Ting WH, Hsieh SW, Chen HH, Wei MC, Lin HH, Hsiao SM*. Predictors for the Recurrence of Clinically Uterine-Confined Endometrial Cancer and the Role of Cytokeratin Immunohistochemistry Stain in the Era of Sentinel Lymph Node Mapping. Cancers (Basel). 2022 Apr 13;14(8):1973. doi: 10.3390/cancers14081973.
  18. Huang PH, Chen YY, Chen HH, Ting WH, Lin HH, Chen KH, Hsiao SM*. Factors affecting clinical outcomes in women with non-gastric gastrointestinal stromal tumors. Taiwan J Obstet Gynecol. 2022 Mar;61(2):306-311. doi: 10.1016/j.tjog.2022.02.019.
  19. Lin TH, Tu FC, Lin HH, Hsiao SM*. Predictors of Clinical Outcome in Women with Pelvic Organ Prolapse Who Underwent Transvaginal Mesh Reconstruction Surgery. Medicina (Kaunas). 2022 Jan 19;58(2):148. doi: 10.3390/medicina58020148.
  20. Liu HM, Lin HH, Hsiao SM*. Predictors of cure and overactive bladder syndrome after a mid-urethral sling procedure in women with stress urinary incontinence. Maturitas. 2022 Feb;156:18-24. doi: 10.1016/j.maturitas.2021.10.016.